Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 7/18/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Kate Bingham?

Kate Bingham

Position, Business Development

Vertex Pharmaceuticals Incorporated

HQ Phone:  (617) 341-6100

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston, Massachusetts,02210

United States

Company Description

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more t...more

Background Information

Employment History

Managing Partner

svlifesciences.com


Head of Technology Media and Telecoms Department

SNR Denton


Affiliations

Autifony Therapeutics Limited

Board Member


Karus Therapeutics Ltd

Board Member


Autifony Therapeutics Limited

Board Member


Oxford University

Advisory Board Member


Kesios Therapeutics Limited

Board Member


Medcity

Advisory Board Member


Pulmocide LTD

Board Member


DDF

Investment Committee As Well As the Investment Committees


Bicycle Therapeutics Limited

Board Member


MedCity Limited

ADVISORY BOARD Member


RespiVert LTD

Board Member


British Venture Capital Association

Council Member


Affibody AB

Board Member


Trine Pharmaceuticals , Inc.

Board Member


Dynogen Pharmaceuticals , Inc.

Board Member


PowderMed Ltd

Board Member


Ingenium Pharmaceuticals GmbH

Member, S Supervisory Board


Nexans SA

Board Member


Metris

Board Member


MedNova

Board Member


LeukoSite

Board Member


Hexagen

Board Member


Cobra

Board Member


Education

MBA

Harvard Business School


Masters degree

Biochemistry

Oxford University


first class degree

Biochemistry

Oxford University


Web References(114 Total References)


Autifony Therapeutics Ltd Board Of Directors

autifony.com [cached]

Kate Bingham
Kate Bingham Kate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed, RespiVert and current investments including Autifony, Bicycle, Convergence and TopiVert. Prior to joining SVLS, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Kate has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA. Kate Bingham


Company - Karus Therapeutics

karustherapeutics.com [cached]

Kate Bingham - Non-executive Director
Kate joined SVLS in 1991. She currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Affinium, Alantos, Auxilium, Convergence, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, MedNova, Micromet, Oncoethix, PowderMed, RespiVert and Vantia and current investments including Atopix, Autifony, Bicycle, Calchan, Kalvista, Karus, Kesios, Pulmocide, TopiVert and VHSquared. Kate has played an active role in setting up the new Dementia Discovery Fund (DDF) and serves on the DDF Investment Committee as well as the Investment Committees for all SVLS's funds. Prior to joining SVLS, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. She has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA (Baker Scholar).


SV Life Sciences Team

svlsm.com [cached]

Kate Bingham
Kate Bingham Managing Partner Kate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Affinium, Alantos, Auxilium, Convergence, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, MedNova, Micromet, Oncoethix, PowderMed, RespiVert and Vantia and current investments including Atopix, Autifony, Bicycle, Calchan, Kalvista, Karus, Pulmocide, TopiVert and VHSquared. Prior to joining SVLS, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Kate has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA.


The Board | Convergence Pharmaceuticals:

www.calchan.co.uk [cached]

Kate Bingham, Managing Partner - SV Life Sciences
Kate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed, RespiVert and current investments including Autifony, Bicycle, Convergence, EUSA and TopiVert. Prior to joining SVLS, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Kate has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA. John Aston OBE John Aston was Chief Financial Officer of Cambridge Antibody Technology (CAT) between 1996 and 2006.


svhealthinvestors.com

Kate Bingham
Managing Partner Send eMail Back to team In her 26 years at SV, Kate's biotech investments have resulted in the launch of six drugs for the treatment of patients with inflammatory and autoimmune disease and cancer. She is one of five Managing Partners serving on the firm's Investment Committee, which managed seven venture capital funds and one public fund (with greater than $2 billion in total assets) for life sciences investing in US and Europe. Kate is responsible for biotech investments and activities in the EU and serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. These investments include small-molecule drug discovery and development projects, biotherapeutic development projects, and drug discovery platforms in a broad range of clinical areas. Kate played an active role in setting up the new Dementia Discovery Fund (DDF) and serves on the DDF Investment Committee. Prior experience Prior to joining SV, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Academic credentials First class degree, Biochemistry, Oxford University; MBA, Harvard Business School (Baker Scholar). Outside of SV Kate won the Lifetime Achievement Award, presented by BioIndustry Association UK in January 2017. She is Deputy Chairman of St Paul's Girls' School, London, and an Investment Committee member of Oxford University Spin-out Equity Management (OSEM). At weekends Kate spends time in Wales where she rides horses and mountain bikes, grows vegetables and competes in bog snorkeling competitions.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory